Search research articles
Contact Us
Filters
Showing results (161-170 of 233) with videos related to
Page
of 24
Sort By:
Ophthalmic Genetics
|
February 18, 2016
Pattern dystrophy in a female carrier of RP2 mutation
Dina Misky, Tremeur Guillaumie, Corinne Baudoin, et al.
Annals of the New York Academy of Sciences
|
January 1, 1979
Risk of asbestosis in crocidolite and amosite mines in South Africa
L M Irwig, R S du Toit, G K Sluis-Cremer, et al.
Scientific Reports
|
May 31, 2018
The effect of PTC124 on choroideremia fibroblasts and iPSC-derived RPE raises considerations for therapy
Simona Torriano, Nejla Erkilic, David Baux, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 30, 2010
Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohort
Olivier Imhoff, Vincent Marion, Corinne Stoetzel, et al.
Molecular Therapy. Methods & Clinical Development
|
May 28, 2015
Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient
Nicolas Cereso, Marie O Pequignot, Lorenne Robert, et al.
Canadian Journal of Physiology and Pharmacology
|
September 1, 1989
The pharmacology of L-670,596, a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonist
A W Ford-Hutchinson, Y Girard, A Lord, et al.
The Journal of Biological Chemistry
|
April 2, 2010
FATP1 inhibits 11-cis retinol formation via interaction with the visual cycle retinoid isomerase RPE65 and lecithin:retinol acyltransferase
Thomas J P Guignard, Minghao Jin, Marie O Pequignot, et al.
Human Mutation
|
May 28, 2010
Dissecting the pathogenic mechanisms of mutations in the pore region of the human cone photoreceptor cyclic nucleotide-gated channel
Katja Koeppen, Peggy Reuter, Thomas Ladewig, et al.
Canadian Journal of Physiology and Pharmacology
|
April 1, 1987
L-641,953 (R-8-fluoro-dibenzo[b, f]thiepin-3-carboxylic acid-5-oxide): a novel thromboxane-prostaglandin endoperoxide antagonist
R A Hall, J R Rokach, P Bélanger, et al.
Ophthalmology
|
January 29, 2011
Systematic screening of BEST1 and PRPH2 in juvenile and adult vitelliform macular dystrophies: a rationale for molecular analysis
Isabelle Meunier, Audrey Sénéchal, Claire-Marie Dhaenens, et al.
Page
of 24
Search research articles
Search
Showing results (161-170 of 233) with videos related to
Sort By:
Page
of 24
Ophthalmic Genetics
|
February 18, 2016
Pattern dystrophy in a female carrier of RP2 mutation
Dina Misky, Tremeur Guillaumie, Corinne Baudoin, et al.
Annals of the New York Academy of Sciences
|
January 1, 1979
Risk of asbestosis in crocidolite and amosite mines in South Africa
L M Irwig, R S du Toit, G K Sluis-Cremer, et al.
Scientific Reports
|
May 31, 2018
The effect of PTC124 on choroideremia fibroblasts and iPSC-derived RPE raises considerations for therapy
Simona Torriano, Nejla Erkilic, David Baux, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
September 30, 2010
Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohort
Olivier Imhoff, Vincent Marion, Corinne Stoetzel, et al.
Molecular Therapy. Methods & Clinical Development
|
May 28, 2015
Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient
Nicolas Cereso, Marie O Pequignot, Lorenne Robert, et al.
Canadian Journal of Physiology and Pharmacology
|
September 1, 1989
The pharmacology of L-670,596, a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonist
A W Ford-Hutchinson, Y Girard, A Lord, et al.
The Journal of Biological Chemistry
|
April 2, 2010
FATP1 inhibits 11-cis retinol formation via interaction with the visual cycle retinoid isomerase RPE65 and lecithin:retinol acyltransferase
Thomas J P Guignard, Minghao Jin, Marie O Pequignot, et al.
Human Mutation
|
May 28, 2010
Dissecting the pathogenic mechanisms of mutations in the pore region of the human cone photoreceptor cyclic nucleotide-gated channel
Katja Koeppen, Peggy Reuter, Thomas Ladewig, et al.
Canadian Journal of Physiology and Pharmacology
|
April 1, 1987
L-641,953 (R-8-fluoro-dibenzo[b, f]thiepin-3-carboxylic acid-5-oxide): a novel thromboxane-prostaglandin endoperoxide antagonist
R A Hall, J R Rokach, P Bélanger, et al.
Ophthalmology
|
January 29, 2011
Systematic screening of BEST1 and PRPH2 in juvenile and adult vitelliform macular dystrophies: a rationale for molecular analysis
Isabelle Meunier, Audrey Sénéchal, Claire-Marie Dhaenens, et al.
Page
of 24